Effect of marine red algal (Portieria hornemannii) extracts on starch digestion rate and its possible role in diabetes management

PS Unnikrishnan, K Suthindhiran, MA Jayasri - Aquaculture International, 2023 - Springer
Marine algae (seaweeds) have emerged as a promising source in the continuing search for
antidiabetic compounds because of their medicinal and nutritional properties. The present …

Tizerpatida: a nova promessa contra a obesidade

GML de Carvalho, LAS Barros - Brazilian Journal of …, 2024 - ojs.brazilianjournals.com.br
A obesidade é uma doença crônica, progressiva, caracterizada pelo acúmulo excessivo de
gordura corporal, que pode levar a diversos riscos à saúde, que afeta cerca de 1 bilhão de …

Tirzepatide: A First-in-class Twincretin for the Management of Type 2 Diabetes

S Jaswal, P Bisht, R Patel, D Parveen… - Letters in Drug …, 2024 - ingentaconnect.com
Background: Tirzepatide (LY3298176) was approved by US Food and Drug Administration
(FDA) on May 13th, 2022. The drug was developed by Eli Lilly and Co. and marketed under …

Potency of Genus Cinnamomum in Addressing Type 2 Diabetes: A Review

B Ilham, U Zubaidah, L Ahadia - … International Conference on …, 2023 - sunankalijaga.org
Abstract Nowadays, type 2 Diabetes Mellitus (T2DM) is denoted as prominent metabolic
disorders worldwide and rank 6 th of disease-associated death in Indonesia. Current T2DM …

[HTML][HTML] Glucagon-Like Peptide-1 Agonists and General Anesthesia: Perioperative Considerations and the Utility of Gastric Ultrasound

CM Willson, L Patel, P Middleton, M Desai - Cureus, 2024 - ncbi.nlm.nih.gov
Abstract Glucagon-like peptide-1 (GLP-1) agonists are very popular and useful medications
for the treatment of type 2 diabetes mellitus and obesity. Potent gastric emptying delay is …

Advent of tirzepatide: boon for diabetic and obese?

A Bhusal - Annals of Medicine and Surgery, 2023 - journals.lww.com
Obesity is defined by WHO as 'an abnormal or excessive fat accumulation that may impair
health'[1, 2]. It is defined as the BMI over 30 kg/m2 in adults [2]. Obesity affecting …

[PDF][PDF] Tirzepatyd–nowy analog hormonów inkretynowych

G Anglart, L Janik, K Dettlaff - Farmacja Polska, 2023 - stn.ump.edu.pl
This article presents the structure of tirzepatide, its mechanism of action, an overview of
clinical trial results, and its safety assessment. Clinical trial results have shown a very …

A nem alkoholos hasnyálmirigy-elzsírosodás klinikai jelentősége

G Jermendy - Orvosi Hetilap, 2022 - akjournals.com
A pancreaticus lipidakkumuláció–amelyet egyre gyakrabban NAFPD (non-alcoholic fatty
pancreas disease) néven említenek az angol nyelvű szakirodalomban–az elmúlt néhány …

[HTML][HTML] Обзор лекарственных средств, одобренных FDA в 2022 году

ДВ Куркин, ЕИ Морковин, ДА Бакулин… - Фармация и …, 2023 - cyberleninka.ru
Цель. Анализ актуальных тенденций зарубежной практики в области разработки и
регистрации лекарственных препаратов. Материалы и методы. При поиске материала …

[HTML][HTML] Glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonists for the treatment of obesity and diabetes mellitus

AC Martins, BG de la Torre… - Exploration of Drug …, 2024 - explorationpub.com
Pharmaceutical interventions play a vital role in managing various conditions, including
weight-related issues such as obesity. In this context, lifestyle changes are often challenging …